Zentalis Pharmaceuticals Llc (ZNTL) stock news · $257.7M cap
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
This ZNTL news page leads with what Zentalis Pharmaceuticals Llc filed — not a scraped headline mill.
No cached 8-K sentence for ZNTL yet. We will not pad this page with generic market recap.
Latest reported ZNTL revenue for 2025-12-31 was $0. Net income was -$137.1M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ZNTL currently screens at market cap $257.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ZNTL stock page; for the tape open the quote page.
ZNTL stock news FAQ
What is ZNTL's latest net income?
Latest cached Zentalis Pharmaceuticals Llc (ZNTL) net income was -$137.1M. Statements: https://lician.com/financials/zntl
What is ZNTL's market cap?
Zentalis Pharmaceuticals Llc (ZNTL) market cap is $257.7M on the latest cached fundamentals snapshot.
What kind of company is ZNTL?
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
Where is ZNTL stock news listed?
Cached stock news for Zentalis Pharmaceuticals Llc (ZNTL) is listed at https://lician.com/news/zntl. Filings: https://lician.com/sec/zntl
Not investment advice.